Metabolic gene defects and risk of arrhythmia

Heart and Metabolism

Volumn , Issue 33, 2006, Pages 9-12

  Ellinor, Patrick T ^a   Milan, David J ^a   MacRae, Calum A ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Cardiovascular Research Center   (United States)

Author keywords

Atrial fibrillation; Fatty acid; Glycogen; Mitochondrial; Ventricular tachycardia

Indexed keywords

ARRHYTHMOGENESIS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CELL TYPE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE DELETION; GENETIC DISORDER; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOSPHINGOLIPID STORAGE DISORDER; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HUMAN; INHERITANCE; LIPID METABOLISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STORAGE DISEASE;

EID: 33846047965     PISSN: 15660338     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913-919.
2. Guertl B, Noehammer C, Hoefler G. Metabolic cardiomyopathies. Int J Exp Pathol. 2000;81:349-372.
3. Bonnet D, Martin D, Pascale De L, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100:2248-2253.
4. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006;142:77-85.
5. Feillet F, Steinmann G, Vianey-Saban C, et al. Adult presentation of MCAD deficiency revealed by coma and severe arrythmias. Intensive Care Med. 2003;29:1594-1597.
6. Spencer CT, Byrne BJ, Gewitz MH, et al. Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. Pediatr Cardiol. 2005;26:632-637.
7. Cantlay AM, Shokrollahi K, Allen JT, Lunt PW, Newbury-Ecob RA, Steward CG. Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr. 1999;135:311-315.
8. Brandner K, Mick DU, Frazier AE, Taylor RD, Meisinger C, Rehling P. Tazl, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome. Mol Biol Cell. 2005;16:5202-5214.
9. Moses SW, Wanderman KL, Myroz A, Frydman M. Cardiac involvement in glycogen storage disease type III. Eur J Pediatr. 1989;148:764-766.
10. Arad M, Benson DW, Perez-Atayde AR, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest. 2002;109:357-362.
11. MacRae CA, Ghaisas N, Kass S, et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. J Clin Invest. 1995;96:1216-1220.
12. Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005;352:362-372.
13. Chimenti C, Pieroni M, Morgante E, et al. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation. 2004;110:1047-1053.
14. Shah JS, Hughes DA, Sachdev B, et al. Prevalence and clinical significance of cardiac arrhythmia in Anderson-Fabry disease. Am J Cardiol. 2005;96:842-846.
15. Anan R, Nakagawa M, Miyata M, et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation. 1995;91:955-961.
16. van Herpen RE, Oude Ophuis RJ, Wijers M, et al. Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors. Mol Cell Biol. 2005;25:1402-1414.
17. Reckova M, Rosengarten C, deAlmeida A, et al. Hemodynamics is a key epigenetic factor in development of the cardiac conduction system. Circ Res. 2003;93:77-85.
18. Arad M, Moskowitz IP, Patel VV, et al. Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy. Circulation. 2003;107:2850-2856.
19. Pieroni M, Chimenti C, De Cobelli F, et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol. 2006;47:1663-1671.
20. Shah M, Akar FG, Tomaselli G. Molecular basis of arrhythmias. Circulation. 2005;112:2517-2529.
21. Thompson RJ, Zhou N, MacVicar BA. Ischemia opens neuronal gap junction hemichannels. Science. 2006;312:924-927.
22. Anderson CL, Delisle BP, Anson BD, et al. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 2006;113:365-373.
23. Huang JM, Xian H, Bacaner M. Long-chain fatty acids activate calcium channels in ventricular myocytes. Proc Natl Acad Sci U S A. 1992;89:6452-6456.